关于神经刺激或调节在心力衰竭患者中疗效的网络元分析
Ping-Tao Tseng1, Bing-Yan Zeng2, Chih-Wei Hsu3
1Institute of Precision Medicine, National Sun Yat-sen University, Kaohsiung City, Taiwan; Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan; Department of Psychology, College of Medical and Health Science, Asia University, Taichung, Taiwan; Prospect Clinic for Otorhinolaryngology & Neurology, Kaohsiung, Taiwan.
Heart rhythm
|April 9, 2025
概括
针对交感和副交感系统的神经刺激,特别是交感神经缩,通过降低大脑天然尿素水平和改善生活质量,显示出对心力衰竭管理的前景.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 医疗技术 医疗技术 医学技术
背景情况:
- 心力衰竭与自主神经系统功能障碍有关,特别是过度活跃的交感性和不太活跃的副交感性活动.
- 神经刺激策略理论上可以解决这种不平衡,但临床证据仍然有限.
研究的目的:
- 系统地审查和比较不同神经刺激和调制技术的有效性,以控制心力衰竭.
- 分析接受这些干预的心力衰竭患者的客观和主观结果.
主要方法:
- 进行了随机对照试验 (RCT) 的频率网络元分析 (NMA).
- 主要结局包括血清脑内尿素 (BNP) 水平和生活质量指标.
主要成果:
- 调节包括血管点在内的交感和副交感系统的干预措施显示出更好的结果.
- 与对照组相比,交感性缩显著降低了BNP水平.
- 巴罗反射激活疗法是唯一显著改善生活质量的干预措施.
结论:
- 这个网络元分析提供了支持心力衰竭特定神经调制技术的比较证据.
- 建议进一步进行高质量,盲目的RCT,以确认这些发现并最大限度地减少偏差.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
329
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
329
01:26Heart Failure Drugs: Inotropic Agents
440
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
440
01:22Heart Failure Drugs: β-Blockers
284
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
284